PVP-I Use Cases

/

July 18, 2025

Protecting Healthcare Workers and Patients: The Role of Povidone-Iodine Mouthwash and Nasal Spray in COVID-19 Prevention

During the peak of the COVID-19 pandemic, healthcare workers faced immense exposure risks—often with limited options for protection beyond PPE. But what if a simple mouthwash or nasal spray could offer an additional line of defense? A comprehensive paper explores how povidone-iodine (PVP-I) products might reduce transmission between patients and health professionals alike. Here's how this low-cost, science-backed solution could play a vital role in infection control.

Blog Image

The Big Idea: Preventing Cross-Infection

This review makes a bold case: povidone-iodine mouthwashes, nasal sprays, drops, and even vapor forms may help break the chain of transmission, especially during aerosol-generating procedures like intubation, suctioning, or dental care.

The authors recommend a proactive protocol using PVP-I to reduce viral load in both patients and healthcare workers before they interact—regardless of a person’s COVID status. The reason? Asymptomatic transmission is real, and viral loads in the nose and mouth can be extremely high—even early in infection.

Why Povidone-Iodine?

  • Kills 99.99% of viruses, including SARS, MERS, and SARS-CoV-2
  • Acts quickly—within 15–30 seconds in vitro
  • Safe for oropharyngeal use, including sprays, gargles, and nasal applications
  • Can be used repeatedly without toxic accumulation or thyroid issues

The Proposed Protocol

The paper suggests using PVP-I mouthwash and nasal spray every 3–4 hours during a healthcare worker’s shift to maintain protection throughout exposure. The same applies to patients before procedures or consultations to reduce airborne viral load.

This isn’t just theory: the authors point to numerous studies and clinical experience where PVP-I use reduced nosocomial (hospital-acquired) infections, even when other interventions failed.

Real-World Impact

Imagine a dentist treating dozens of patients a day—or a nurse conducting nasal swabs in a busy testing center. Adding PVP-I as a pre-contact rinse or spray could meaningfully lower the risk of virus transfer, especially when layered with masks and hand hygiene.

It’s not a replacement for vaccines or PPE—but it could be an important bridge, especially in lower-resource settings or during surges when staff are most vulnerable.

Final Thoughts

This review builds a compelling case for including PVP-I nasal and oral protocols in COVID-19 prevention—especially in clinical settings. It’s cheap, safe, and effective. As we rethink infection control post-pandemic, povidone-iodine might just be the unsung hero we need more of.

Explore the full paper here: The Role of Povidone Iodine Mouthwash & Nasal Spray or Drop or Inhalation for Protection

No items found.
Author Image

Suscribe to our newsletter

At risus viverra adipiscing at in tellus integer feugiat nisl pretiua

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Subscribe to our email newsletter for explorers!

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.